Amgen (AMGN) is trading near 52-week highs, up 8% in the latest session, signaling institutional interest. Q4 revenues rose 9% to $9.9 billion, with full-year revenues up 10% to $36.8 billion. AMGN’s stock has risen 13.7% in the last three months and 11% year-to-date, with a forward P/E of 15.6x.

The breakout for AMGN stock is supported by strong fundamentals, with revenue growth at 10% and a diversified product portfolio. Key catalysts include portfolio expansion and pipeline progress. Wall Street’s price targets are rising, indicating improving sentiment. AMGN’s forward P/E of 15.6x offers a different risk/reward profile compared to tech stocks.

AMGN’s earnings profile remains solid, with current-year EPS at $22.33 and next-year EPS expected near $22.92. The market is underestimating the company’s durability and margin resilience. Consensus expects continued execution from AMGN’s lineup, with whispers suggesting newer assets will translate into multi-year revenue streams. Key catalysts ahead include portfolio expansion and pipeline progress.

The next phase of the AI explosion is set to create significant wealth for investors. Zacks’ AI Boom 2.0 report reveals 4 under-the-radar companies that may be the next stars in AI’s evolution. Investors can access the report for free to learn more about these potential investment opportunities.

Read more at Nasdaq: Amgen (AMGN) Stock Hits 52-Week Highs: Buy Signal?